Register For Our Mailing List

Register to receive our free weekly newsletter including editorials.

Home / 348

Coronavirus and a roadmap for infected investing

(Update on 15 March 2020. The numbers in Roger's article were up-to-date on Wednesday 11 March 2020. While we will not rewrite the article, it is noteworthy that Italy had a spike in new virus cases and deaths at the end of the week, and the US (especially Donald Trump) is finally reacting seriously by declaring a national emergency. As Roger observes, developments in the US in the coming weeks will be a major factor in how markets perform. We now know coronavirus will have lasting impacts on the way business and society operates in future).  

With the data changing daily, the only things moving faster than the spread of coronavirus are the financial markets. In this exclusive note for Firstlinks, we explore the possible paths the stock market might take in the next few weeks and months, noting short-term predictions are a very high-risk venture.

This too shall pass

Indeed, on the subject of short-term predictions, it’s worth sharing the 19th-century retelling of a Persian fable by both the English poet Edward FitzGerald and US President Abraham Lincoln.

When an Eastern sage was desired by his sultan to inscribe on a ring the sentiment which, amidst the perpetual change of human affairs, was most descriptive of their real tendency, he engraved on it the words: "And this, too, shall pass away."

FitzGerald retold it thus:

“It is said an Eastern monarch once charged his wise men to invent him a sentence, to be ever in view, and which should be true and appropriate in all times and situations. They presented him the words: "And this, too, shall pass away." How much it expresses! How chastening in the hour of pride! How consoling in the depths of affliction!”

When considering how deeply the world might be afflicted by Covid-19 it is worth remembering that we will not even be talking about it in five years’ time. Acknowledging the tragedy that the outbreak has already wrought on families all over the world is important. Notwithstanding, humans are resilient and adaptable and a solution will be found. When we look back, the virus will have been contained, a vaccine developed, and the world will move forward.

The viral and financial market contagions that could occur in the interim, and which have been demonstrated already, are worth considering, if only to try and anticipate when it might be best to venture a purchase of shares at prices that may not be revisited for a decade.

We care about the answers to this question deeply if only because, like Berkshire Hathaway, we also approach the crisis with about 30% of our portfolios in cash.

The success story in South Korea

We have been tracking the data daily, including the number of tests being conducted. This is important because you only find something when you are looking for it.

South Korea has published 183 updates since the start of the outbreak. This may be a function of their level of concern, which itself is a function of the country’s proximity to China. Regardless, at some point they realised they had a problem and began testing in earnest. As at the time of writing, South Korea has conducted 4,000 tests per one million head of population, or 210,000 tests in 10 days.

As a result of the tests, South Korea has produced a detection rate of 3.58% (obviously the infection rate is higher because not everyone is being tested and many are quarantining themselves at home).

Table 1. South Korea

Source: Montgomery Small Companies Fund

As the data in Table 1 reveals, of the 210,000 tests, 7,513 have been confirmed with Covid-19 (3.58%). Of the 7,513 confirmed cases, 54 people (0.7%) have died, 96% have been quarantined and 3.3% have been discharged. Given that testing is continuing and that there is a large cohort who have been quarantined and are therefore unresolved the fatality rate of 0.7% is likely to go up.

But South Korea’s story is one of relative success, being able to isolate the outbreak to a death cult, and thye rapidly ramped up their testing.

The challenge in Italy

Italy, by contrast, is a basket case and the poster child of the consequences of a poor response.

As we write this note, Italy is experiencing the first economically and socially significant outbreak outside of China and South Korea. Italy is also the first liberal democracy to enforce a country-wide lockdown. Until today, the country had implemented a haphazard approach to lockdowns, confined to the Lombardy region. I say ‘haphazard’ because eyewitnesses at the sieve-like boarder control roadblocks reported cyclists and vehicles moving through the checkpoints unimpeded.

Italians turned up late to admitting there was a problem and consequently we have seen their numbers explode.

Italy today has only conducted a quarter of the number of tests per million (1000 tests/million population) that South Korea has conducted. And because those tests commenced late, they have been shocked to discover a detection rate of 16.7%. Italy only really started testing on 24 February with 4324 tests, but the number then fell away and it was not until 7 March that testing numbers again exceeded those earlier numbers. 

As at today (10 March), the Italians have only tested 0.1% of their population and already they have experienced almost 12 times the number of deaths (631) as South Korea. As Figure 1 illustrates, this is the result of commencing and then scaling testing late.

Figure 1. Italian cumulative tests and positive results.

Source: Montgomery Small Companies Fund

Figure 2 makes an observation that should be troubling for the US and therefore for the markets. As the rate of testing goes up in a country that is late to commence, the number of confirmed cases understandably surprises.

Figure 2. Italian daily tests and confirmations

US is slow to move

To show how late the United States is to respond to the outbreak, the CDC (Centers for Disease Control and Prevention) has thus far reported only 26 tests have been conducted per million population. The US CDC spotted coronavirus in January but left it to public sector laboratories to develop a test. It has obviously taken some time because by the end of February, the US had averaged 92 tests per day in a country of 340 million people! Today, the testing is beginning to scale and 810 tests were conducted on 6 March 2020.

If they scale effectively, what will the US find? They will report a high detection rate, much higher than the 7.5% detection rate as of 10 March 2020. Of the 647 confirmed cases, 4.3% have died. This number will rise too. Italy appears to be offering a road map.

A limiting factor is that Amercians do not kiss each other as a greeting, the US population is younger and the frequency of smokers is lower. However, a large number of people could die.

Short-term implications for equity markets

So, is it time to start buying the dips in shares again? The answer is probably not. Of course, there will be companies that are affected by the virus directly and if their share prices overreact negatively at any time, investors should ask whether the company’s ills are being treated as permanent. If the market is treating the issue as permanent, but it proves to be temporary, an opportunity could be presented. Keep that in mind.

The US could soon experience a parabolic jump in the number of confirmed cases as they scale up their testing. This means broad-based value may yet be just around the corner.

 

Roger Montgomery is Chairman and Chief Investment Officer at Montgomery Investment Management. This article is for general information only and does not consider the circumstances of any individual.

 

12 Comments
Roger Montgomery
March 20, 2020

Bill, for the many many billions who survive, investing will remain a concern.

Grietje Croll
March 19, 2020

Great information. But I would like some information about what is happening in Australia. What is the testing percentage here? And the trajectory sofar?

Roger Montgomery
March 20, 2020

Australia is doing a phenomenal job of testing. On a per capita basis we are just behind South Korea who has been the global leader. NSW has conducted 35,800 tests and only 297 have come back positive. This is a Detection rate of less than 1%. Keeping in mind Australia has just closed its borders and is making congregating in public places unappealing, or even illegal, I think you can worry less.

Ramani
March 15, 2020

'This too shall pass' is no less true of the aphorism, so the time for it to pass might pass the investor's needs by. So it all comes to one's risk appetite ('at what price fall will you contemplate jumping off the cliff?') and the ability to tide over transient crashes ('do you need to resort to fire sales?')
This is particularly true for super where other than unrestricted non-preserved, the saver is imprisoned in the system (preserved) or on parole (restricted non-preserved). Unlike other savers, super members cannot get out, only exchange jails. This sobering reflection should prevent crystallising losses especially for those fully in pension phase as no tax relief is available.
Good on the funds which highlight this, but punters are entitled to take such advice with a pinch of salt. Not many have counselled savers to actively shift their investment choices from equities whenever they experience irrational exuberance. Outsider trading triggers lemming-like imitation, proving Frankin's warning about confusing motion with movement.

Roger Montgomery
March 20, 2020

Hi Ramani,
Thanks for sharing your thoughts on our article. Philosophy is not as helpful as action. Please look back at our blog. There you will find we consistently and frequently warned investors to actively shift from equities during irrational exuberance. If you took those warnings with a pinch of salt, where would you be?

Ruth from Brisbane
March 13, 2020

Roger thanks for more info about Italy, South Korea and USA. Asset prices have been over-valued for some time all fueled by debt esp QE. Covid-19 is not the cause of a crash, just a trigger to bring down the debt-fueled house of cards. But there's a lot of cash around as well waiting for an opportunity. I won't be setting my alarm clock to buy tomorrow morning though! Like the GFC, assets and resources have not left the planet, but their ownership will change.

Roger Montgomery
March 20, 2020

Thanks Ruth. This too shall pass.

Joey
March 13, 2020

Good point that we have not seen the impact of testing in the US. Also, as Graham Hand's comments point out, the whole of South America. So number of cases only likely to rise.

Roger Montgomery
March 20, 2020

Yes sir. The worst of the detections and fatalaties are ahead. The trick is working out whether the market has assumed even worse already.

Brendan
March 12, 2020

Roger, I enjoy your work, but it sounds a touch dismissive to say we won't be talking about this in five years' time. This share market fall/crash caused by the virus may be the first young investors may have experienced, and this will be formative in their quest to become rational, long term investors. They will and should cite this when it inevitably happens again. Multiply this if the crash keeps going.

Bill
March 16, 2020

Agreed. With only 2000 ventilators in Australia, if you are over 60, stay at home and lock the doors and don’t let anyone in. Border closures and complete lock down was required 2 weeks ago. The horse has bolted. Investing is the least of anyone’s concerns.

Roger Montgomery
March 20, 2020

Irrespective of an investor's age, its the right perspective to take.

 

Leave a Comment:

     

RELATED ARTICLES

Is currency exposure an unwanted risk or source of returns?

COVID-19 and the madness of crowds

After 30 years of investing, I prefer to skip this party

banner

Most viewed in recent weeks

10 little-known pension traps prove the value of advice

Most people entering retirement do not see a financial adviser, mainly due to cost. It's a major problem because there are small mistakes a retiree can make which are expensive and avoidable if a few tips were known.

Check eligibility for the Commonwealth Seniors Health Card

Eligibility for the Commonwealth Seniors Health Card has no asset test and a relatively high income test. It's worth checking eligibility and the benefits of qualifying to save on the cost of medications.

Hamish Douglass on why the movie hasn’t ended yet

The focus is on Magellan for its investment performance and departure of the CEO, but Douglass says the pandemic, inflation, rising rates and Middle East tensions have not played out. Vindication is always long term.

Start the year right with the 2022 Retiree Checklist

This is our annual checklist of what retirees need to be aware of in 2022. It is a long list of 25 items and not everything will apply to your situation. Run your eye over the benefits and entitlements.

At 98-years-old, Charlie Munger still delivers the one-liners

The Warren Buffett/Charlie Munger partnership is the stuff of legends, but even Charlie admits it is coming to an end ("I'm nearly dead"). He is one of the few people in investing prepared to say what he thinks.

Should I pay off the mortgage or top up my superannuation?

Depending on personal circumstances, it may be time to rethink the bias to paying down housing debt over wealth accumulation in super. Do the sums and ask these four questions to plan for your future.

Latest Updates

Investment strategies

Three ways index investing masks extra risk

There are thousands of different indexes, and they are not all diversified and broadly-based. Watch for concentration risk in sectors and companies, and know the underlying assets in case liquidity is needed.

Investment strategies

Will 2022 be the year for quality companies?

It is easy to feel like an investing genius over the last 10 years, with most asset classes making wonderful gains. But if there's a setback, companies like Reece, ARB, Cochlear, REA Group and CSL will recover best.

Shares

2022 outlook: buy a raincoat but don't put it on yet

In the 11th year of a bull market, near the end of the cycle, some type of correction is likely. Underneath is solid, healthy and underpinned by strong earnings growth, but there's less room for mistakes.

Gold

Time to give up on gold?

In 2021, the gold price failed to sustain its strong rise since 2018, although it recovered after early losses. But where does gold sit in a world of inflation, rising rates and a competitor like Bitcoin?

Investment strategies

Global leaders reveal surprises of 2021, challenges for 2022

In a sentence or two, global experts across many fields are asked to summarise the biggest surprise of 2021, and enduring challenges into 2022. It's a short and sweet view of the changes we are all facing.

Shares

What were the big stockmarket listings in record 2021?

In 2021, sharemarket gains supported record levels of capital raisings and IPOs in Australia. The range of deals listed here shows the maturity of the local market in providing equity capital.

Economy

Let 'er rip: how high can debt-to-GDP ratios soar?

Governments and investors have been complacent about the build up of debt, but at some level, a ceiling exists. Are we near yet? Trouble is brewing, especially in the eurozone and emerging countries.

Sponsors

Alliances

© 2022 Morningstar, Inc. All rights reserved.

Disclaimer
The data, research and opinions provided here are for information purposes; are not an offer to buy or sell a security; and are not warranted to be correct, complete or accurate. Morningstar, its affiliates, and third-party content providers are not responsible for any investment decisions, damages or losses resulting from, or related to, the data and analyses or their use. Any general advice or ‘regulated financial advice’ under New Zealand law has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Ltd, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. For more information refer to our Financial Services Guide (AU) and Financial Advice Provider Disclosure Statement (NZ). You should consider the advice in light of these matters and if applicable, the relevant Product Disclosure Statement before making any decision to invest. Past performance does not necessarily indicate a financial product’s future performance. To obtain advice tailored to your situation, contact a professional financial adviser. Articles are current as at date of publication.
This website contains information and opinions provided by third parties. Inclusion of this information does not necessarily represent Morningstar’s positions, strategies or opinions and should not be considered an endorsement by Morningstar.

Website Development by Master Publisher.